Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma ExperienceAdela Canete, Mary Gerrard, Hervé Rubie, et al.International Journal of Cancer|December 14, 2007
Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE)Caroline Munzer, Florence Menegaux, Brigitte Lacour, et al.International Journal of Cancer|January 31, 2019
Parental smoking, maternal alcohol consumption during pregnancy and the risk of neuroblastoma in children. A pooled analysis of the ESCALE and ESTELLE French studiesPaula Rios, Helen D Bailey, Claire Poulalhon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplificationBruno De Bernardi, Mary Gerrard, Luca Boni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group StudyHervé Rubie, Julia Chisholm, Anne Sophie Defachelles, et al.Cancer|August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplificationAnne Laprie, Jean Michon, Olivier Hartmann, et al.BMC Infectious Diseases|June 12, 2024
Compliance with antibiotic therapy guidelines in french paediatric intensive care units: a multicentre observational studyRomain Amadieu, Camille Brehin, Adéla Chahine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.European Journal of Cancer (Oxford, England : 1990)|September 12, 2013
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyAngela Di Giannatale, Nathalie Dias-Gastellier, Annick Devos, et al.Pediatric Blood & Cancer|August 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN StudyJulie Savagner, Caroline Munzer, Gudrun Schleiermacher, et al.Pageof 3